Oncology Times(@OncologyTimes) 's Twitter Profile Photo

Adding checkpoint inhibition immunotherapy to adjuvant did not improve survival among patients with triple-negative , according to a new study. Heather McArthur, MD, MPH, discusses the results in this : ow.ly/6k5s50Rfo0F Heather McArthur, MD, MPH

Adding checkpoint inhibition immunotherapy to adjuvant #chemotherapy did not improve survival among patients with triple-negative #breastcancer, according to a new study. Heather McArthur, MD, MPH, discusses the results in this #podcast: ow.ly/6k5s50Rfo0F @hmcarthur
account_circle
Jai Prakash(@Prakash_UTwente) 's Twitter Profile Photo

ERC Advanced Grant

I am highly honoured to announce that I have been awarded with the ERC Advanced grant of 2.5 million euro for 5 years to unravel the ECM remodeling in cancer and study its impact on immunotherapy in pancreatic tumor.

ERC Advanced Grant

I am highly honoured to announce that I have been awarded with the ERC Advanced grant of 2.5 million euro for 5 years to unravel the ECM remodeling in cancer and study its impact on immunotherapy in pancreatic tumor.
account_circle
Ovarian Cancer Action(@OvarianCancerUK) 's Twitter Profile Photo

What is immunotherapy? 🧬

Immunotherapy is a new and effective treatment that turns the body’s immune system against cancer. It boosts the body’s immune system, enabling it to recognise and eliminate cancer cells whilst leaving healthy cells alone.

What is immunotherapy? 🧬

Immunotherapy is a new and effective treatment that turns the body’s immune system against cancer. It boosts the body’s immune system, enabling it to recognise and eliminate cancer cells whilst leaving healthy cells alone.
account_circle
Mariam Hanna MD(@PedsAllergyDoc) 's Twitter Profile Photo

We are still working on the definitions of outcomes of oral immunotherapy. It’s not all the same AND we don’t even have our terminology sorted out - yet! Keyword here: YET!

account_circle
Pharmacological Research(@PharmacolRes) 's Twitter Profile Photo

Amazing systematic review and meta-analysis discussing the opportunities and challenges of the disease-modifying immunotherapy for type 1 diabetes: doi.org/10.1016/j.phrs…

Amazing systematic review and meta-analysis discussing the opportunities and challenges of the disease-modifying immunotherapy for type 1 diabetes: doi.org/10.1016/j.phrs…
#diabetes #immunotherapy #PharmacolRes #openaccess #Research #PharmaTwitter #MedTwitter
account_circle
Mayo Clinic(@MayoClinic) 's Twitter Profile Photo

CAR-T cell therapy has put some blood cancers in remission. Mayo Clinic researchers are studying ways to expand this immunotherapy to solid tumors in thyroid cancer. First, they must jump four hurdles.

Learn more: mayocl.in/3UdMIm1

account_circle
Mariam Hanna MD(@PedsAllergyDoc) 's Twitter Profile Photo

Don’t lump all oral immunotherapy together.

When looking at challenge defined outcomes, may not correlate with patient defined outcomes

Remission has been shown to improve QOL in patients that can achieve this!

account_circle
Fong Voon Ken(@Ironken6) 's Twitter Profile Photo

AKI Related to Cancer Immunotherapy: Can Biomarkers Help by Sebastian Lapman

Immune checkpoint inhibitors unleash the immune system to recognize and destroy cancer cells more effectively. Yet, they are associated with risk of AKI.

The potential biomarkers are as such:

AKI Related to Cancer Immunotherapy: Can Biomarkers Help by Sebastian Lapman

Immune checkpoint inhibitors unleash the immune system to recognize and destroy cancer cells more effectively. Yet, they are associated with risk of AKI.

The potential biomarkers are as such:

#ISNWCN
account_circle
Jarushka Naidoo(@DrJNaidoo) 's Twitter Profile Photo

Keynote Speaker

Thanks Dr. Julie Brahmer for a stellar presentation on immunotherapy: the beginning, the middle, the future. Areas of need:
- IO tox
- IO resistance
- academic studies on relevant questions: e.g. IO duration

IASLC #IrishLungCancerAlliance Johns Hopkins Thoracic Oncology

#AILCC24 Keynote Speaker 

Thanks @JulieBrahmer for a stellar presentation on immunotherapy: the beginning, the middle, the future. Areas of need:
- IO tox 
- IO resistance
- academic studies on relevant questions: e.g. IO duration

@IASLC @IrishLungCancer @HopkinsThoracic  #LCSM
account_circle
Mike Linn(@TheCancerSutra) 's Twitter Profile Photo

Cancer is so indiscriminate and harsh that it can erase years of animosity instantly when you find out someone has it.

During my first diagnosis, I was doing an immunotherapy infusion, and who would happen to sit next to me?

My college track coach, who I absolutely loathed.…

account_circle
Saint Jezebel is trying to love herself(@kshandra) 's Twitter Profile Photo

With one session of immunotherapy remaining and my return to work on the horizon, it is time to start winding down my fundraiser.

Thank you all. I’ll be paying this forward for the rest of my days. gofund.me/48986d0a

account_circle
Rasheed Zakaria(@zakaria_neuro) 's Twitter Profile Photo

Next BNOS webinar 25th April 4pm 🇬🇧

has been transformative for some of our patients with but why haven’t we seen the results hoped for with ?

Chiba Ene + Sophie Berghoff MedUni Wien discuss

eventbrite.co.uk/e/bnos-transla…

account_circle